Thursday, May 29, 2014

DMEMEDS shared post via Reuters: Trimel's sexual disorder drug effective in mid-stage study

(Reuters) - Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in women with an orgasmic disorder in a second mid-stage study. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/BZk85ZJWjEI/story01.htm

Read More

No comments:

Post a Comment

Subscribe Now: Feed Icon